← Back to Clinical Trials
Recruiting NCT02450006

NCT02450006 Intermountain INSPIRE Registry

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT02450006
Status Recruiting
Phase —
Sponsor Intermountain Health Care, Inc.
Condition Condition
Study Type OBSERVATIONAL
Enrollment 50,000 participants
Start Date 2015-04
Primary Completion 2050-04

Eligibility & Interventions

Sex All sexes
Min Age N/A
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 50,000 participants in total. It began in 2015-04 with a primary completion date of 2050-04.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

To collect biological samples, clinical information and laboratory data from patients diagnosed with any healthcare-related conditions who are seen at facilities affiliated with Intermountain Healthcare, including patients and their family members, and to collect the same information and samples from a general population including disease-free subjects.

Eligibility Criteria

Inclusion Criteria: * Males or females of any age, any ethnicity, diagnosed with any healthcare-related conditions, presenting to an Intermountain Healthcare-affiliated facility or males or females of any age, any ethnicity, with or without any healthcare-related conditions, including disease-free subjects, from a general population that may include unaffected family members * Patient or patient's representative has the ability to understand and sign a written informed consent form, which must be obtained prior to initiation of any study procedures, using a form that is approved by the applicable IRB. Exclusion Criteria: * Inability or refusal of the patient and/or the patient's legally-acceptable representative to provide informed consent for any reason. * Other conditions that in the opinion of the Principal Investigator or Co-Investigator(s) may increase risk to the subject and/or compromise the quality of the registry project.

Contact & Investigator

Central Contact

Joseph B Muhlestein, MD

✉ brent.muhlestein@imail.org

📞 801-507-4701

Frequently Asked Questions

Who can join the NCT02450006 clinical trial?

This trial is open to participants of all sexes, studying Condition. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT02450006 currently recruiting?

Yes, NCT02450006 is actively recruiting participants. Contact the research team at brent.muhlestein@imail.org for enrollment information.

Where is the NCT02450006 trial being conducted?

This trial is being conducted at Murray, United States.

Who is sponsoring the NCT02450006 clinical trial?

NCT02450006 is sponsored by Intermountain Health Care, Inc.. The trial plans to enroll 50,000 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology